366 related articles for article (PubMed ID: 30914761)
1. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro.
Yu P; Wang HY; Tian M; Li AX; Chen XS; Wang XL; Zhang Y; Cheng Y
Acta Pharmacol Sin; 2019 Sep; 40(9):1237-1244. PubMed ID: 30914761
[TBL] [Abstract][Full Text] [Related]
2. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
3. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.
Cheng Y; Ren X; Zhang Y; Patel R; Sharma A; Wu H; Robertson GP; Yan L; Rubin E; Yang JM
Cancer Res; 2011 Apr; 71(7):2654-63. PubMed ID: 21307130
[TBL] [Abstract][Full Text] [Related]
4. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
[TBL] [Abstract][Full Text] [Related]
5. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
Li S; Li Y; Bai Y
Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
[TBL] [Abstract][Full Text] [Related]
6. Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro.
Guan YD; Jiang SL; Yu P; Wen M; Zhang Y; Xiao SS; Xu XJ; Cheng Y
Acta Pharmacol Sin; 2018 Apr; 39(4):642-648. PubMed ID: 29239350
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy.
Guan Y; Jiang S; Ye W; Ren X; Wang X; Zhang Y; Yin M; Wang K; Tao Y; Yang J; Cao D; Cheng Y
Cell Death Dis; 2020 Nov; 11(11):948. PubMed ID: 33144562
[TBL] [Abstract][Full Text] [Related]
8. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
[TBL] [Abstract][Full Text] [Related]
9. A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses.
Py BF; Boyce M; Yuan J
Autophagy; 2009 Apr; 5(3):393-6. PubMed ID: 19221463
[TBL] [Abstract][Full Text] [Related]
10. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
Huber-Keener KJ; Evans BR; Ren X; Cheng Y; Zhang Y; Hait WN; Yang JM
Biochem Biophys Res Commun; 2012 Jul; 424(2):308-14. PubMed ID: 22749997
[TBL] [Abstract][Full Text] [Related]
12. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
[TBL] [Abstract][Full Text] [Related]
13. eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.
Cheng Y; Ren X; Yuan Y; Shan Y; Li L; Chen X; Zhang L; Takahashi Y; Yang JW; Han B; Liao J; Li Y; Harvey H; Ryazanov A; Robertson GP; Wan G; Liu D; Chen AF; Tao Y; Yang JM
Oncogene; 2016 Dec; 35(49):6293-6308. PubMed ID: 27181208
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.
Zhao YY; Tian Y; Liu L; Zhan JH; Hou X; Chen X; Zhou T; Huang Y; Zhang L
Drug Des Devel Ther; 2018; 12():2655-2663. PubMed ID: 30214154
[TBL] [Abstract][Full Text] [Related]
15. The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells.
Choi Y; Lee JH
Cancer Biol Ther; 2011 Dec; 12(11):989-96. PubMed ID: 22123175
[TBL] [Abstract][Full Text] [Related]
16. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
[TBL] [Abstract][Full Text] [Related]
18. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
20. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.
Piserchio A; Long KJ; Browning LS; Bohanon AL; Isiorho EA; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300902120. PubMed ID: 37068230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
